139 related articles for article (PubMed ID: 36889238)
1. Brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion.
Gubbiotti MA; Livolsi V
Clin Neurol Neurosurg; 2023 Apr; 227():107639. PubMed ID: 36889238
[TBL] [Abstract][Full Text] [Related]
2. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma].
Zhang M; Duan HL; Wang LM; Gao W; Yao YY; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1234-1239. PubMed ID: 34719160
[No Abstract] [Full Text] [Related]
4. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
Xu B; Tuttle RM; Sabra MM; Ganly I; Ghossein R
Thyroid; 2017 May; 27(5):632-640. PubMed ID: 28049366
[TBL] [Abstract][Full Text] [Related]
5. Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
Stenman A; Koman A; Ihre-Lundgren C; Juhlin CC
Medicine (Baltimore); 2021 Jan; 100(2):e24237. PubMed ID: 33466206
[TBL] [Abstract][Full Text] [Related]
6. Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma: Molecular Characterization by Next-Generation Sequencing and Histopathological Comparison With Tall Cell Papillary Carcinoma of Thyroid.
Zhong E; Scognamiglio T; D'Alfonso T; Song W; Tran H; Baek I; Hoda SA
Int J Surg Pathol; 2019 Apr; 27(2):134-141. PubMed ID: 30227763
[TBL] [Abstract][Full Text] [Related]
7. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.
Bournaud C; Descotes F; Decaussin-Petrucci M; Berthiller J; de la Fouchardière C; Giraudet AL; Bertholon-Gregoire M; Robinson P; Lifante JC; Lopez J; Borson-Chazot F
Eur J Cancer; 2019 Feb; 108():41-49. PubMed ID: 30648628
[TBL] [Abstract][Full Text] [Related]
8. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.
Virk RK; Van Dyke AL; Finkelstein A; Prasad A; Gibson J; Hui P; Theoharis CG; Carling T; Roman SA; Sosa JA; Udelsman R; Prasad ML
Mod Pathol; 2013 Jan; 26(1):62-70. PubMed ID: 22918165
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
[TBL] [Abstract][Full Text] [Related]
10. PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.
Davidson M; Olsen RJ; Ewton AA; Robbins RJ
Endocr Pract; 2017 Dec; 23(12):1425-1429. PubMed ID: 29144798
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma.
Morandi L; Righi A; Maletta F; Rucci P; Pagni F; Gallo M; Rossi S; Caporali L; Sapino A; Lloyd RV; Asioli S
Endocr Relat Cancer; 2017 Feb; 24(2):107-117. PubMed ID: 28062544
[TBL] [Abstract][Full Text] [Related]
12. Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid.
Nath MC; Erickson LA
Adv Anat Pathol; 2018 May; 25(3):172-179. PubMed ID: 29351089
[TBL] [Abstract][Full Text] [Related]
13. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
[TBL] [Abstract][Full Text] [Related]
14. TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
Melo M; Gaspar da Rocha A; Batista R; Vinagre J; Martins MJ; Costa G; Ribeiro C; Carrilho F; Leite V; Lobo C; Cameselle-Teijeiro JM; Cavadas B; Pereira L; Sobrinho-Simões M; Soares P
J Clin Endocrinol Metab; 2017 Jun; 102(6):1898-1907. PubMed ID: 28323937
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma.
Na HY; Yu HW; Kim W; Moon JH; Ahn CH; Choi SI; Kim YK; Choi JY; Park SY
Clin Endocrinol (Oxf); 2022 Jul; 97(1):106-115. PubMed ID: 35343605
[TBL] [Abstract][Full Text] [Related]
16. BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas.
Sancisi V; Nicoli D; Ragazzi M; Piana S; Ciarrocchi A
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1745-9. PubMed ID: 22740704
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
18. Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation.
Odate T; Oishi N; Kawai M; Tahara I; Mochizuki K; Akaishi J; Ito K; Katoh R; Kondo T
Endocr Pathol; 2021 Sep; 32(3):347-356. PubMed ID: 33761111
[TBL] [Abstract][Full Text] [Related]
19. [Seven cases of brain metastasis from papillary thyroid carcinoma].
Ikekubo K; Hino M; Ito H; Hirao K; Ueshima M; Tanaka T; Kobayashi H; Ishihara T; Kurahachi H
Kaku Igaku; 2000 Jul; 37(4):349-57. PubMed ID: 10965656
[TBL] [Abstract][Full Text] [Related]
20. [Histopatological and molecular genetic characteristics of clinically aggressive variants of papillary thyroid carcinoma].
Bogolyubova AV; Abrosimov AY; Selivanova LS; Belousov PV
Arkh Patol; 2019; 81(1):46-51. PubMed ID: 30830105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
